Infectious Diseases drugs
13 results
Anthim (obiltoxaximab)
(obiltoxaximab)Elusys Therapeutics, Inc.
Usage: ANTHIM is indicated for treating inhalational anthrax in adults and pediatric patients, alongside antibacterial drugs. It is also used for prophylaxis when alternative treatments are unavailable, although risks of hypersensitivity must be considered. ANTHIM works by binding to anthrax toxins, not possessing direct antibacterial properties.
Beyfortus (nirsevimab)
(nirsevimab)Sanofi Pasteur Inc.
Usage: BEYFORTUS is indicated for preventing Respiratory Syncytial Virus (RSV) lower respiratory tract disease in neonates and infants during their first RSV season and in children up to 24 months at risk of severe RSV disease through their second RSV season.
Cresemba (isavuconazonium sulfate)
(isavuconazonium sulfate)Astellas Pharma US, Inc.
Usage: CRESEMBA is indicated for the treatment of invasive aspergillosis and invasive mucormycosis in adults and pediatric patients, with different age and weight requirements for injection and capsule formulations. Prior laboratory tests to identify the causative organisms should be conducted before starting therapy.
Ebanga (ansuvimab)
(ANSUVIMAB)Ridgeback Biotherapeutics, LP
Usage: EBANGA is indicated for treating infections caused by Zaire ebolavirus in adult and pediatric patients, including neonates born to RT-PCR positive mothers. Its efficacy for other Ebolavirus or Marburgvirus species is not established, and clinical benefits may diminish due to resistance or viral changes.
Elmiron (pentosan polysulfate sodium)
(PENTOSAN POLYSULFATE SODIUM)Janssen Pharmaceuticals, Inc.
Usage: ELMIRON® (pentosan polysulfate sodium) is indicated for relieving bladder pain or discomfort associated with interstitial cystitis.
Kedrab (human rabies virus immune globulin)
(HUMAN RABIES VIRUS IMMUNE GLOBULIN)Kedrion Biopharma Inc.
Usage: KEDRAB is indicated for passive, transient post-exposure prophylaxis of rabies infection in individuals of all ages, administered immediately after contact with a rabid or possibly rabid animal, and should be given alongside a full course of rabies vaccine.
Lampit (nifurtimox)
(nifurtimox)Bayer Healthcare Pharmaceuticals INC.
Usage: LAMPIT is indicated for the treatment of Chagas disease (American Trypanosomiasis) in pediatric patients aged birth to less than 18 years who weigh at least 2.5 kg, caused by *Trypanosoma cruzi*.
Rapivab (peramivir)
(peramivir)BioCryst Pharmaceuticals, Inc.
Usage: RAPIVAB is indicated for treating acute uncomplicated influenza in patients aged 6 months and older, with symptoms lasting no more than 2 days. Its efficacy is primarily based on trials for influenza A, with limitations regarding resistance and effectiveness in severely ill patients.
Rezzayo (rezafungin)
(rezafungin)Melinta Therapeutics, LLC
Usage: REZZAYO is indicated for patients aged 18 or older with limited treatment options for candidemia and invasive candidiasis. It has not been studied for endocarditis, osteomyelitis, or meningitis due to Candida. Initiate therapy before culture results but adjust as needed once results are available.
Synagis (palivizumab)
(palivizumab)Swedish Orphan Biovitrum AB (publ)
Usage: Synagis is indicated for preventing serious lower respiratory tract disease caused by RSV in pediatric patients with a history of premature birth, bronchopulmonary dysplasia requiring treatment, or hemodynamically significant congenital heart disease, all under specific age limits at the start of RSV season.